$RNXT
RenovoRx, Inc.

2022 Q4 Form 10-Q Financial Statement

#000149315222031491 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.394M $1.315M $628.0K
YoY Change 11.08% 109.39%
% of Gross Profit
Research & Development $776.0K $846.0K $767.0K
YoY Change -29.52% 10.3%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.170M $2.161M $1.395M
YoY Change -7.89% 54.91%
Operating Profit -$2.161M -$1.395M
YoY Change 54.91%
Interest Expense $14.00K $22.00K -$208.0K
YoY Change 1300.0% -110.58%
% of Operating Profit
Other Income/Expense, Net $0.00 $25.00K $170.0K
YoY Change -85.29%
Pretax Income -$2.156M -$2.136M -$1.511M
YoY Change -8.45% 41.36%
Income Tax
% Of Pretax Income
Net Earnings -$2.156M -$2.136M -$1.511M
YoY Change -8.45% 41.36%
Net Earnings / Revenue
Basic Earnings Per Share -$0.24 -$0.27
Diluted Earnings Per Share -$0.24 -$235.6K -$268.9K
COMMON SHARES
Basic Shares Outstanding 9.098M shares 9.067M shares 5.620M shares
Diluted Shares Outstanding 9.068M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.440M $8.114M $17.73M
YoY Change -57.61% -54.22%
Cash & Equivalents $4.391M $3.093M $17.73M
Short-Term Investments $2.049M $5.021M
Other Short-Term Assets $825.0K $1.136M $439.0K
YoY Change -24.24% 158.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.265M $9.250M $18.16M
YoY Change -55.38% -49.08%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.000K
YoY Change
Total Long-Term Assets $0.00 $0.00 $14.00K
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $7.265M $9.250M $18.16M
Total Long-Term Assets $0.00 $0.00 $14.00K
Total Assets $7.265M $9.250M $18.18M
YoY Change -55.39% -49.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $534.0K $538.0K $133.0K
YoY Change 1.71% 304.51%
Accrued Expenses $568.0K $564.0K $492.0K
YoY Change 37.53% 14.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $1.102M $1.102M $625.0K
YoY Change 17.48% 76.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.102M $1.102M $625.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.102M $1.102M $625.0K
YoY Change 17.48% 76.32%
SHAREHOLDERS EQUITY
Retained Earnings -$31.20M -$29.00M
YoY Change 46.59%
Common Stock $37.32M $37.15M
YoY Change 1.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.163M $8.148M $17.55M
YoY Change
Total Liabilities & Shareholders Equity $7.265M $9.250M $18.18M
YoY Change -55.39% -49.11%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.156M -$2.136M -$1.511M
YoY Change -8.45% 41.36%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.681M -$2.672M -$1.119M
YoY Change -34.28% 138.78%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.976M $2.992M
YoY Change
Cash From Investing Activities $2.976M $2.992M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $17.29M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.000K 4.000K 17.29M
YoY Change -88.0% -99.98%
NET CHANGE
Cash From Operating Activities -1.681M -2.672M -1.119M
Cash From Investing Activities 2.976M 2.992M 0.000
Cash From Financing Activities 3.000K 4.000K 17.29M
Net Change In Cash 1.298M 324.0K 16.17M
YoY Change -151.24% -98.0%
FREE CASH FLOW
Cash From Operating Activities -$1.681M -$2.672M -$1.119M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$1.681M -$2.672M -$1.119M
YoY Change -34.28% 138.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001574094
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q3 RNXT Leasehold Improvements Net
LeaseholdImprovementsNet
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax
OtherComprehensiveIncomeLossTransfersFromHeldToMaturityToAvailableForSaleSecuritiesNetOfTax
usd
us-gaap Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax
OtherComprehensiveIncomeLossTransfersFromHeldToMaturityToAvailableForSaleSecuritiesNetOfTax
usd
CY2021Q3 RNXT Stock Issued During Period Value Reverse Stock Splits
StockIssuedDuringPeriodValueReverseStockSplits
usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
RNXT Gain On Loan Extinguishment From Ppp Loan
GainOnLoanExtinguishmentFromPppLoan
usd
RNXT Loss On Loan Extinguishment From Convertible Notes
LossOnLoanExtinguishmentFromConvertibleNotes
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
RNXT Payments For Leasehold Improvements
PaymentsForLeaseholdImprovements
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
RNXT Derivative Liability In Financing Activities
DerivativeLiabilityInFinancingActivities
usd
RNXT Conversion Of Convertible Preferred Stock Upon Initial Public Offering
ConversionOfConvertiblePreferredStockUponInitialPublicOffering
usd
RNXT Conversion Of Convertible Notes Upon Initial Public Offering
ConversionOfConvertibleNotesUponInitialPublicOffering
usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9097701 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3093000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15192000 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5021000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1136000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1089000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40738
dei Entity Registrant Name
EntityRegistrantName
RENOVORX, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1448452
dei Entity Address Address Line1
EntityAddressAddressLine1
4546 El Camino Real
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite B1
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Altos
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94022
dei City Area Code
CityAreaCode
(650)
dei Local Phone Number
LocalPhoneNumber
284-4433
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
RNXT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 us-gaap Assets Current
AssetsCurrent
9250000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
16281000 usd
CY2021Q4 RNXT Leasehold Improvements Net
LeaseholdImprovementsNet
6000 usd
CY2022Q3 us-gaap Assets
Assets
9250000 usd
CY2021Q4 us-gaap Assets
Assets
16287000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
538000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
525000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
564000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
413000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1102000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
938000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2136000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-654000 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9072263 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9072263 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8933989 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8933989 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
37151000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36632000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
13000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29017000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21284000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8148000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15349000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9250000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16287000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
846000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
767000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3525000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1938000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1315000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
628000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4255000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1377000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2161000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1395000 usd
us-gaap Operating Expenses
OperatingExpenses
7780000 usd
us-gaap Operating Expenses
OperatingExpenses
3315000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2161000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1395000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7780000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3315000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
22000 usd
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-208000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
43000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-835000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
170000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
119000 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-78000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
62000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-116000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
47000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1511000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7733000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3969000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax
OtherComprehensiveIncomeLossTransfersFromHeldToMaturityToAvailableForSaleSecuritiesNetOfTax
17000 usd
us-gaap Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax
OtherComprehensiveIncomeLossTransfersFromHeldToMaturityToAvailableForSaleSecuritiesNetOfTax
13000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2119000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1511000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7720000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3969000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9067509 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5620135 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9039308 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3640988 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15349000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
14000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
154000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3003000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
12540000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
169000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2594000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10120000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
143000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2136000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
8148000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-14656000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1148000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-15762000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1310000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-17060000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-17060000 usd
CY2021Q3 RNXT Stock Issued During Period Value Conversion Of Convertible Preferred Stock To Common Stock
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockToCommonStock
12451000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5279000 usd
CY2021Q3 RNXT Reclassification Of Derivative Liability Upon Conversion Of Convertible Notes
ReclassificationOfDerivativeLiabilityUponConversionOfConvertibleNotes
1101000 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14561000 usd
CY2021Q3 RNXT Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2675000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1511000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
17553000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7733000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3969000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
480000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21000 usd
RNXT Amortization On Leasehold Improvement
AmortizationOnLeaseholdImprovement
6000 usd
RNXT Amortization On Leasehold Improvement
AmortizationOnLeaseholdImprovement
5000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
118000 usd
RNXT Gain On Loan Extinguishment From Ppp Loan
GainOnLoanExtinguishmentFromPppLoan
140000 usd
RNXT Loss On Loan Extinguishment From Convertible Notes
LossOnLoanExtinguishmentFromConvertibleNotes
78000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
697000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
47000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
324000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-29000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
151000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
421000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7130000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3358000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2992000 usd
RNXT Payments For Leasehold Improvements
PaymentsForLeaseholdImprovements
15000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5008000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
14561000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2675000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1977000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
39000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
90000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19303000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12099000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15930000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15192000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1795000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3093000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17725000 usd
RNXT Derivative Liability In Financing Activities
DerivativeLiabilityInFinancingActivities
738000 usd
RNXT Conversion Of Convertible Preferred Stock Upon Initial Public Offering
ConversionOfConvertiblePreferredStockUponInitialPublicOffering
12451000 usd
RNXT Conversion Of Convertible Notes Upon Initial Public Offering
ConversionOfConvertibleNotesUponInitialPublicOffering
5279000 usd
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-5 reverse stock split
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
8100000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7700000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29000000.0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
50000000.0 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.80
CY2022Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
2800000 usd
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
15000000.0 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5008000 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
13000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
5021000 usd
CY2022Q3 RNXT Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
226000 usd
CY2021Q4 RNXT Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
358000 usd
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
269000 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
33000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
69000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
564000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
413000 usd
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Company leases its headquarters in Los Altos, California under a month-to-month operating lease agreement.
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
18000 usd
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
18000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
54000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
42000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
926379 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.08
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M19D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2856000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
494031 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.65
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
134774 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
86328 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.94
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1199308 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M15D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
717000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
640898 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M25D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
712000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1199308 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y5M15D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
717000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
700000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y5M1D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2786995 shares
us-gaap Share Based Compensation
ShareBasedCompensation
21000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0123 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.4166 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.4213 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M8D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0304 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0062 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0100 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
143000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
6000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
480000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
143000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
6000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
480000 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.80
RNXT Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Contractual Term1
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageContractualTerm1
P4Y8M1D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
30100000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2786995 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
10.80
RNXT Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Contractual Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageContractualTerm
P3Y11M1D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
30100000 usd
CY2021Q3 RNXT Accrued Interest Or Penalty Related To Uncertain Tax Positions
AccruedInterestOrPenaltyRelatedToUncertainTaxPositions
0 usd
CY2022Q3 RNXT Accrued Interest Or Penalty Related To Uncertain Tax Positions
AccruedInterestOrPenaltyRelatedToUncertainTaxPositions
0 usd
RNXT Accrued Interest Or Penalty Related To Uncertain Tax Positions
AccruedInterestOrPenaltyRelatedToUncertainTaxPositions
0 usd
RNXT Accrued Interest Or Penalty Related To Uncertain Tax Positions
AccruedInterestOrPenaltyRelatedToUncertainTaxPositions
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2136000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1511000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7733000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3969000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9067509 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5620135 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9039308 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3640988 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
484518 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
878895 shares

Files In Submission

Name View Source Status
0001493152-22-031491-index-headers.html Edgar Link pending
0001493152-22-031491-index.html Edgar Link pending
0001493152-22-031491.txt Edgar Link pending
0001493152-22-031491-xbrl.zip Edgar Link pending
ex10-3.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rnxt-20220930.xsd Edgar Link pending
rnxt-20220930_cal.xml Edgar Link unprocessable
rnxt-20220930_def.xml Edgar Link unprocessable
rnxt-20220930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
Show.js Edgar Link pending
rnxt-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable